Abiopharma

🔍 HESSE DANIEL (Director)

Company: PNC FINANCIAL SERVICES GROUP, INC. (PNC)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 69 shares of Phantom Stock Unit (Derivative)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 4,868.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F2
• Holds 2,116 shares of Phantom Stock Unit (Derivative)
  Date: 2026-04-01 | Code: H | shares_owned_after: 2,116.00 | Footnotes: F1, F1, F1, F3
• Holds 11,718 shares of Deferred Stock Unit (Derivative)
  Date: 2026-04-01 | Code: H | shares_owned_after: 11,718.00 | Footnotes: F4, F4, F4, F5

Footnotes:

• F1: One phantom stock unit is the economic equivalent of one share of The PNC Financial Services Group, Inc. ("PNC") common stock. Phantom stock units will be settled in cash upon distribution to the reporting person and generally do not expire.
• F2: Includes phantom stock units acquired by the reporting person as dividend equivalents under the PNC Deferred Compensation Plan in transactions exempt from reporting that occurred after the date of the reporting person's most recent filing on Form 4.
• F3: Includes phantom stock units acquired by the reporting person as dividend equivalents under the PNC Outside Directors Deferred Stock Unit Plan in transactions exempt from reporting that occurred after the date of the reporting person's most recent filing on Form 4.
• F4: Deferred stock units ("DSUs") granted pursuant to the PNC Directors Deferred Stock Unit Program (the "Program") under PNC's 2016 Incentive Award Plan. Each DSU represents the right to receive at retirement one share of PNC common stock, or in limited circumstances cash equal to the fair market value of one share of PNC common stock on the payment determination date, pursuant to the terms of the Program.
• F5: Includes DSUs acquired by the reporting person as dividend equivalents under the Program in transactions exempt from reporting that occurred after the date of the reporting person's most recent filing on Form 4.